Systemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation.

Reijerkerk, Arie

Systemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation. [electronic resource] - Investigative ophthalmology & visual science Apr 2014 - 2788-94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1552-5783

10.1167/iovs.13-13599 doi


Animals
Autoimmune Diseases--drug therapy
Disease Models, Animal
Drug Combinations
Glucocorticoids--administration & dosage
Glutathione--administration & dosage
Immunohistochemistry
Liposomes
Male
Methylprednisolone--administration & dosage
Rats
Rats, Inbred Lew
Treatment Outcome
Uveitis--drug therapy